REG - Cirata PLC - Director/PDMR Shareholding

CirataAnnouncement

17/11/2023 18:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231117:nRSQ8948Ta&default-theme=true

RNS Number : 8948T  Cirata PLC  17 November 2023

 17  November 2023

 

Cirata plc

("Cirata" or the "Company")

Director/PDMR Shareholdings

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities

 

Cirata plc (LSE: CRTA) provides the following notification of a transaction by
persons discharging managerial responsibilities ("PDMR").

 

On 17 November 2023, Mr Stephen Kelly, Chief Executive Officer, purchased
248,600 Ordinary Shares in Cirata at a price of 48 pence per Ordinary Share.
Following this purchase and on completion of the Allotment Award share
matching transaction, Mr Stephen Kelly will be the beneficial owner of
2,032,600 Ordinary Shares representing approximately 1.76% of the Company's
"when issued" share capital.

 

The total beneficial shareholding of 2,032,600 Ordinary Shares  is comprised
of  open market purchases by Mr Stephen Kelly totalling 1,182,680 Ordinary
Shares, plus the company's share Allotment Award of 850,000 1  (#_ftn1)
Ordinary Shares, giving a total beneficial ownership post allotment of
2,032,600 Ordinary Shares.

 

The following represents the Director dealing

 

 Buying PMDR            Ordinary shares purchased  Price of Ordinary Shares acquired, 17 November 2023  Total beneficial interest post purchase
 Mr Stephen Kelly, CEO  248,600                    48 pence                                                1,182,680

 

The following represents the Directors beneficial interest post the "Allotment
Award" Shares

 

 Transaction                                                 Shares / %
 Shareholding as of COB 16 Nov 23                            1,182,680
 Allotment Award Shares                                      850,000
 Total beneficial Interest post Allotment Award              2,032,680
 % beneficial Ordinary Share ownership post Allotment Award  1.76%

 

"Allotment Award"/Allotment Award Shares"

 

As previously disclosed on 3 July "Launch of Fund Fundraise" under the terms
of Mr Stephen Kelly's service agreement, the Company has agreed (up to a
capped limit) that during the 12-month period from the commencement of
service, for every Ordinary Share purchased by Mr Stephen Kelly in the open
market the Company will issue and allot on a 1-1 basis a match to this
purchase.  This shall be limited to a maximum value of 1 times £425,000
(based on the price per Ordinary Share paid) (the "Allotment Award Shares").

 

The number of shares purchased by Mr Stephen Kelly that are eligible for a
match have exceeded the capped limit of £425,000 (The book value of open
market purchases to date is approximately £545,000). As a result, under the
terms of the Allotment Award, Mr Stephen Kelly will be issued a further
850,000 Ordinary Shares. The Allotment Award Shares will be issued by the
financial year end 2023. 2  (#_ftn2)

 

The Notification of Dealing Form for this transaction is included at the end
of this announcement.

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the company's obligations under Article 17 of
MAR.

 

This announcement contains information that qualifies or may qualify as inside
information. The person responsible for arranging the release of this
announcement on behalf of Cirata plc is Larry Webster, Company Secretary.

 

 Cirata plc                                     Via FTI Consulting
 Stephen Kelly, Chief Executive Officer
 Ijoma Maluza, Chief Financial Officer
 Daniel Hayes, Investor Relations

 FTI Consulting                                 +44 (0)20 3727 1137
 Matt Dixon / Kwaku Aning / Usama Ali

 Stifel (Nomad and Joint Broker)                +44 (0)20 7710 7600
 Fred Walsh / Richard Short / Tom Marsh

 Liberum (Joint Broker)                         +44 (0)20 3100 2000
 Max Jones / Ben Cryer / Miquela Bezuidenhoudt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

About Cirata

 

Cirata accelerates data-driven revenue growth by automating data transfer and
integration to modern cloud analytics and AI platforms without downtime or
disruption. With Cirata, data leaders can leverage the power of AI and
analytics across their entire enterprise data estate to freely choose
analytics technologies, avoid vendor, platform, or cloud lock-in while making
AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of
products and technology solutions make strategic adoption of modern data
analytics efficient and automated. For more information about Cirata,
visit www.cirata.com (http://www.cirata.com)

 

 

 

 

 

 

 

 

 

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Stephen Kelly

 2    Reason for the notification

 a)   Position/status                                              Chief Executive Officer

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Cirata plc

 b)   LEI                                                          213800Y1A75RSC698O04
 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares 10 p each

      Identification code

                                                                   ISIN: JE00B6Y3DV84
 b)   Nature of the transaction                                    Purchase of Ordinary Shares

 c)   Price(s) and volume(s)                                       Price(s)  Volume(s)

                                                                   48 pence  248,600
 d)   Aggregated information

      - Aggregated volume                                          248,600

      - Price

                                                                   48 pence
 e)   Date of the transaction                                      17 October 2023

 f)   Place of the transaction                                     London Stock Exchange (XLON)

d)

 

Aggregated information

- Aggregated volume

- Price

 

248,600

 

48 pence

e)

 

Date of the transaction

17 October 2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 1  (#_ftnref1) The number of shares allocated (850,00)  is derived by taking
the agreed value cap of £425,000 and dividing by the purchase price per share
(50 pence per share) of Mr Stephen Kelly's open market trades.

(#_ftnref2)

 2  The Company's issued share capital at 1 November 2023 consisted of
114,898,711 ordinary shares of ten pence each with voting rights admitted to
trading. The Company holds no ordinary shares in Treasury. Upon completion
of the Allotment Share Awards the issued share capital will increase by
850,000 shares leading to a total of 115,748,711 issued share capital.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBRBDBXUBDGXR